GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
LIVE

Serial Number

88086496

Owner

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Attorney

Keith Barritt

First Use Date

Jul 8, 2020

Filing Date

Aug 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML) Trademark

Serial Number: 88086496 • Registration: 6169996

GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML) is a trademark filed by SUN PHARMACEUTICAL INDUSTRIES LIMITED on August 21, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SUN PHARMACEUTICAL INDUSTRIES LIMITED (296 trademarks)

VADODARA, GUJARAT 390012 , IN

Entity Type: 16

Trademark Details

Filing Date

August 21, 2018

Registration Date

October 6, 2020

First Use Anywhere

July 8, 2020

First Use in Commerce

July 8, 2020

Published for Opposition

January 29, 2019

Goods & Services

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 6, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 6, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 3, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 2, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Aug 13, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 13, 2020 AITU
USE AMENDMENT FILED
Aug 4, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 4, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2020 EXRA
SOU EXTENSION 2 GRANTED
Mar 18, 2020 EX2G
SOU EXTENSION 2 FILED
Mar 18, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 18, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 21, 2019 EXRA
SOU EXTENSION 1 GRANTED
Sep 19, 2019 EX1G
SOU EXTENSION 1 FILED
Sep 19, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 19, 2019 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 26, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 29, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 29, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 9, 2019 NONP
ASSIGNED TO LIE
Dec 21, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 29, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 29, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 29, 2018 CNEA
ASSIGNED TO EXAMINER
Nov 27, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 30, 2018 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 29, 2018 NWOS
NEW APPLICATION ENTERED
Aug 24, 2018 NWAP